PMID- 25706090 OWN - NLM STAT- MEDLINE DCOM- 20160307 LR - 20220408 IS - 1651-2316 (Electronic) IS - 1650-6073 (Print) IS - 1650-6073 (Linking) VI - 44 IP - 4 DP - 2015 TI - Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data. PG - 314-27 LID - 10.1080/16506073.2015.1012740 [doi] AB - Brain-derived neurotrophic factor (BDNF) is associated with synaptic plasticity, which is crucial for long-term learning and memory. Some studies suggest that people suffering from anxiety disorders show reduced BDNF relative to healthy controls. Lower BDNF is associated with impaired learning, cognitive deficits, and poor exposure-based treatment outcomes. A series of studies with rats showed that exercise elevates BDNF and enhances fear extinction. However, this strategy has not been tested in humans. In this pilot study, we randomized participants (N = 9, 8 females, M(Age) = 34) with posttraumatic stress disorder (PTSD) to (a) prolonged exposure alone (PE) or (b) prolonged exposure+exercise (PE+E). Participants randomized to the PE+E condition completed a 30-minute bout of moderate-intensity treadmill exercise (70% of age-predicted HR(max)) prior to each PE session. Consistent with prediction, the PE+E group showed a greater improvement in PTSD symptoms (d = 2.65) and elevated BDNF (d = 1.08) relative to the PE only condition. This pilot study provides initial support for further investigation into exercise augmented exposure therapy. FAU - Powers, Mark B AU - Powers MB AD - a Department of Psychology, Institute for Mental Health Research , The University of Texas at Austin , Austin , TX , USA. FAU - Medina, Johnna L AU - Medina JL FAU - Burns, Stephanie AU - Burns S FAU - Kauffman, Brooke Y AU - Kauffman BY FAU - Monfils, Marie AU - Monfils M FAU - Asmundson, Gordon J G AU - Asmundson GJ FAU - Diamond, Allison AU - Diamond A FAU - McIntyre, Christa AU - McIntyre C FAU - Smits, Jasper A J AU - Smits JA LA - eng SI - ClinicalTrials.gov/NCT01199107 GR - F31 DA036919/DA/NIDA NIH HHS/United States GR - R01 MH091147/MH/NIMH NIH HHS/United States GR - R01 DA027533/DA/NIDA NIH HHS/United States GR - K01 DA035930/DA/NIDA NIH HHS/United States GR - R15 MH099655/MH/NIMH NIH HHS/United States PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural DEP - 20150223 PL - England TA - Cogn Behav Ther JT - Cognitive behaviour therapy JID - 101143317 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - Adult MH - Brain-Derived Neurotrophic Factor/*blood MH - Combined Modality Therapy/methods MH - Exercise/*psychology MH - Exercise Therapy/*methods MH - Female MH - Humans MH - Implosive Therapy/*methods MH - Male MH - Pilot Projects MH - Stress Disorders, Post-Traumatic/blood/*therapy MH - Young Adult PMC - PMC4464974 MID - NIHMS682582 OTO - NOTNLM OT - BDNF OT - CBT OT - anxiety disorders OT - augmentation OT - exercise OT - exposure therapy OT - pilot data EDAT- 2015/02/24 06:00 MHDA- 2016/03/08 06:00 PMCR- 2016/06/01 CRDT- 2015/02/24 06:00 PHST- 2015/02/24 06:00 [entrez] PHST- 2015/02/24 06:00 [pubmed] PHST- 2016/03/08 06:00 [medline] PHST- 2016/06/01 00:00 [pmc-release] AID - 10.1080/16506073.2015.1012740 [doi] PST - ppublish SO - Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. Epub 2015 Feb 23.